Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

QNXT

iShares Nasdaq-100 ex Top 30 ETF (QNXT)

Rating:72Outperform
Price Target:$34.00▲(10.86% Upside)

QNXT’s rating suggests it is a solid but not top-tier ETF, supported by several strong, growing companies. Key holdings like ASML and Qualcomm boost the fund’s quality through robust financial performance, positive momentum, and strategic growth initiatives, while other leaders such as Gilead and Vertex add stability with strong earnings and focused pipelines. However, weaker names like Starbucks and Booking Holdings, which face high leverage, valuation concerns, and bearish technical trends, along with the fund’s meaningful exposure to tech and growth-oriented stocks, introduce risk if market conditions turn against these sectors.

Positive Factors
Strong Overall Year-to-Date PerformanceThe ETF has delivered strong gains so far this year, showing solid momentum for investors who have held it over the longer recent period.
Healthy Performance from Key Technology and Health Care HoldingsSeveral of the largest positions, especially in technology and health care, have shown strong performance, helping support the fund’s returns.
Moderate Expense RatioThe fund’s fee is relatively low for a specialized ETF, which helps investors keep more of the returns generated by the portfolio.
Negative Factors
Heavy U.S. Market ConcentrationAlmost all of the ETF’s holdings are in U.S. companies, which means performance is highly tied to the health of the U.S. stock market.
Sector Tilt Toward TechnologyA large portion of the fund is invested in technology stocks, making it more sensitive to swings in that sector than a more balanced market fund.
Mixed Results Among Top HoldingsWhile many top positions have performed well, a few larger holdings have shown weak or negative performance, which can drag on overall returns.

QNXT vs. SPDR S&P 500 ETF (SPY)

-5%0%5%10%15%20%25%SPY+14.55%QNXT+15.77%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
27.71M
Region
North America
Expense Ratio
0.20%
Beta
1.06
Issuer
iShares
Inception Date
Oct 23, 2024
Dividend Yield
0.71%
Asset Class
Equity
Index Tracked
Nasdaq-100 ex Top 30 Index - Benchmark TR Net

QNXT Summary

QNXT is an ETF that follows the Nasdaq-100 ex Top 30 Index, meaning it invests in many of the next-tier large companies in the Nasdaq, but leaves out the 30 biggest names. It mainly holds U.S. stocks in technology, healthcare, and consumer businesses. Well-known companies in the fund include Shopify and Qualcomm. Someone might invest in QNXT to seek growth from innovative firms while avoiding heavy concentration in the largest tech giants. A key risk is that it is still heavily tied to the stock market and tech-related sectors, so its value can go up and down significantly.

How much will it cost me?

This ETF has an expense ratio of 0.20%, which means you’ll pay about $2 per year for every $1,000 you invest. That’s slightly higher than the cheapest index ETFs, because it tracks a more specialized version of the Nasdaq-100 rather than a very broad, plain-vanilla market index.

What would affect this ETF?

This ETF is heavily tilted toward U.S. technology, healthcare, and consumer companies like Shopify, Qualcomm, and Gilead, so it could benefit if innovation, online spending, and medical advances continue to grow and if interest rates eventually ease, supporting higher stock prices. On the downside, it may be hurt by rising interest rates, slower U.S. economic growth, tighter tech and healthcare regulations, or weaker consumer spending, and because it excludes the largest Nasdaq names, it could lag if those mega-cap stocks strongly outperform.

QNXT Top 10 Holdings

QNXT leans heavily into U.S. tech and healthcare, with a bench of “next-tier” innovators doing most of the heavy lifting. Analog Devices and ASML are key tech engines, generally rising but occasionally hitting speed bumps when valuations look stretched. Western Digital has been a standout, surging on renewed demand and giving the fund extra torque. On the healthcare side, Gilead and Vertex are steady climbers, helping smooth volatility. Offsetting that strength, Qualcomm and Intuitive Surgical have been more mixed, at times losing steam and trimming some of the fund’s momentum.

QNXT top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
GILDGILDGilead Sciences3.97%$1.10M$208.48B34.25%78Outperform
ADIADIAnalog Devices3.78%$1.05M$192.84B67.55%78Outperform
QCOMQCOMQualcomm3.54%$981.71K$184.54B-1.16%80Outperform
SHOPSHOPShopify――――77Outperform
ISRGISRGIntuitive Surgical2.96%$819.95K$153.77B-21.56%78Outperform
ASMLASMLASML Holding2.68%$742.57K$563.74B46.60%81Outperform
VRTXVRTXVertex Pharmaceuticals2.62%$726.03K$136.56B23.95%78Outperform
ADPADPAutomatic Data Processing2.33%$645.40K$122.35B21.73%70Outperform
SBUXSBUXStarbucks2.33%$645.28K$121.35B23.14%56Neutral
BKNGBKNGBooking Holdings2.31%$639.16K$118.68B-21.40%63Neutral

QNXT Technical Analysis

Technical Analysis SentimentNegative
Last Price30.67

Price Trends

50DMA30.83Negative
100DMA31.04Negative
200DMA29.74Positive

Market Momentum

MACD-0.10Negative
RSI48.53Neutral
STOCH79.00Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QNXT, the sentiment is Negative. The current price of 30.67 is below the 20-day moving average (MA) of 30.79, below the 50-day MA of 30.83, and above the 200-day MA of 29.74, indicating a neutral trend. The MACD of -0.10 indicates Negative momentum. The RSI at 48.53 is Neutral, neither overbought nor oversold. The STOCH value of 79.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for QNXT.

QNXT Peer Comparison

Comparison Results

QNXT against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
QNXTQNXT$30.67$34.00(10.86% Upside)$27.71M0.20%72Outperform
HAWGHAWG$29.50$36.70(24.42% Upside)$100.71M1.35%73Outperform
PRMRPRMR$28.31$34.21(20.81% Upside)$93.61M1.00%73Outperform
NULCNULC$54.06$66.64(23.26% Upside)$87.06M0.21%73Outperform
SPXESPXE$80.92$98.14(21.28% Upside)$85.41M0.09%74Outperform
QARPQARP$69.80$79.80(14.32% Upside)$80.07M0.19%73Outperform

Performance Comparison

0%10%20%QNXTHAWGPRMRNULCSPXEQARPDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
QNXT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
QNXTiShares Nasdaq-100 ex Top 30 ETF30.674.0915.37%
HAWGHCM Hedged Equity ETF29.50-0.76-2.52%
PRMRPeakShares RMR Prime Equity ETF28.313.3313.34%
NULCNuveen ESG Large-Cap ETF54.067.6316.43%
SPXEProShares S&P 500 Ex-Energy ETF80.929.6713.58%
QARPXtrackers Russell 1000 US Quality at a Reasonable Price ETF69.8013.4023.75%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.